For sale order India Irisa Trocai 13701351540 supply price

Contact Zhang Xian for Iressa ordering phone number in India
Iressa (gefitinib) is a new type of small molecular weight tumor treatment drug. Its mechanism of action is mainly to block conduction by inhibiting autophosphorylation. Inhibit the proliferation of tumor cells and achieve targeted therapy.
Iressa is mainly used clinically to treat locally advanced or metastatic non-small cell lung cancer that has received chemotherapy in the past. It is especially effective for lung adenocarcinoma. Its efficacy for squamous cell carcinoma is lower than that of adenocarcinoma and alveolar carcinoma. However, a large amount of clinical data shows that after treatment with Iressa (gefitinib) based on the actual conditions of lung cancer patients, some patients with lung squamous cell carcinoma and other non-small cell lung cancer still have obvious effects and are well tolerated.
Drug Introduction Iressa, a targeted therapy drug that was officially approved for marketing by the European Medicines Agency (European Medicines Agency) in Europe on March 1, is suitable for first-line, locally advanced or metastatic non-small cell lung cancer with genetic mutations in adults. The second- and third-line authorities in Beijing and Shanghai respectively reported that there are survival cases of patients who have been taking Iressa for more than 20 years. Basic properties of Iressa
Drug name Iressa
Generic name Gefitinib
English name
Ingredient Gefiti
Manufacturer Asli
Packaging/Dosage Form Film-coated Tablets
Storage/Expiration Date Save Validity Period Months
Buy in India Easy Ressa cash on delivery